H1B Salary Data

Home › Employers › Pathology Associates of Greenville, P.A.

Pathology Associates of Greenville, P.A.: H-1B salaries and sponsorship

Pathology Associates of Greenville, P.A. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $300,000.

Applications (LCAs)3
Certified3
Employer addressGreenville, SC
H-1B dependent employerNo
Median offered salary$300,000
Middle half of salaries$290,000–$312,500
10th–90th percentile$284,000–$320,000

Does Pathology Associates of Greenville, P.A. sponsor H-1B visas?

Pathology Associates of Greenville, P.A. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Feb 5, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Pathologist1$300,000
Physician (Pathologist)1$280,000
Physician1$325,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$300,000
FY20241$280,000
FY20261$325,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Physician$325,000
Level I
Columbia, SCFeb 5, 2026Jul 1, 2026Certified
Physician (Pathologist)$280,000
Level II
Columbia, SCMay 28, 2024Jul 30, 2024Certified
Pathologist$300,000
Level II
Columbia, SCJun 2, 2023Jul 10, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).